HCA Healthcare, Inc. (NYSE:HCA) Stock Has Average Target Price of $467.61

Shares of HCA Healthcare, Inc. (NYSE:HCA) have received an average rating of “Moderate Buy” from the twenty-four analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $467.61.

HCA has been the topic of several research reports. JPMorgan Chase & Co. decreased their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research note on Thursday, August 20th. TD Cowen boosted their price objective on shares of HCA Healthcare from $431.00 to $460.00 and gave the company a “buy” rating in a research report on Monday, October 12th. Oppenheimer lowered their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Morgan Stanley dropped their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Finally, Truist Financial cut their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th.

Institutional Investors Weigh In On HCA Healthcare

Large investors have recently made changes to their positions in the business. MidFirst Bank bought a new stake in HCA Healthcare in the 2nd quarter worth approximately $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare in the second quarter worth about $29,000. Cedar Mountain Advisors LLC bought a new stake in HCA Healthcare during the 1st quarter worth approximately $33,000. Delos Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $35,000. Finally, Merkkuri Wealth Advisors LLC bought a new stake in HCA Healthcare during the first quarter valued at about $43,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 0.7%

HCA stock opened at $455.53 on Friday. The company’s 50 day moving average is $427.22 and its 200 day moving average is $418.81. The stock has a market cap of $98.62 billion, a price-to-earnings ratio of 15.44, a price-to-earnings-growth ratio of 1.55 and a beta of 1.10. HCA Healthcare has a 1-year low of $353.99 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the firm posted $6.84 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts forecast that HCA Healthcare will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were issued a $0.78 dividend. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.